BCM
MRTX

BluePath Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

BluePath Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-894
Closed -$38.9K – 339
2023
Q3 		$38.9K Buy
+894
New +$38.9K 0.04% 203